
One year after MFN: How US policy is reshaping the global pharma model
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOdGpHQXZiNkdheG1fcnc0SHdKaktrckg3OThVWDZ0M1lhMVZDY3pjbWxfVG11UHBxVmVRX1FYbWxlSnhMd0FzY2E2bXFYamZkTTZXTlVjWnZ3TEtHeDR6RFcyTHU1WTdJbnM2YlR5SHR3UFVsbm12TEVkaGk3aXBxRlZoWTFOS0VHUHl2am5SckFaeVpYVGdrYXl3U1h4bk5wUFJF?oc=5" target="_blank">One year after MFN: How US policy is reshaping the global pharma model</a>&nbsp;&nbsp;<font color="#6f6f6f">pharmaphorum</font>

